By Alan Mozes HealthDay Reporter THURSDAY, April 7, 2022 (HealthDay News) — The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progression… Continue reading Could HIV Meds Help Slow Advanced Cancers?
WEDNESDAY, March 16, 2022 (HealthDay News) — Ever since routine prostate-specific antigen (PSA) screening tests have no longer been recommended, there has been a troubling rise in advanced prostate cancer cases in the United States, new research has found. The tests measure the amount of PSA in the blood, and elevated levels can signal the… Continue reading With Fewer PSA Tests, Rate of Advanced Prostate Cancers Rose
But preventable cases of the disease could surge in black and Asian groups, analysis suggests. Source link
WEDNESDAY, Feb. 9, 2022 (HealthDay News) — An experimental therapy that harnesses the body’s tumor-fighting immune cells may be effective for some women with advanced breast cancer, early research suggests. The findings come from an ongoing trial at the U.S. National Cancer Institute (NCI). It is testing a new approach to treating women whose breast… Continue reading Immune-Based Therapy Shows Promise Against Advanced Breast Cancers
Routine checks for cervical cancer may help uncover other tumours elsewhere, research suggests. Source link
Jan. 12, 2022 — A recent headline about dramatic reductions in cervical cancer among young women as a result of the HPV vaccine did not tell the whole story of how vaccination could also have an impact on many other cancer types.
Even with the good news of cervical cancer rates dropping dramatically,… Continue reading HPV Vaccine Could Shifts Rates of Non-Cervical Cancers
Photo Credit: DNY59 / Getty Images SOURCES: Amanda Maddalone, financial planning program manager, Family Reach. American Cancer Society: “Treating Breast Cancer,” “The Costs of Cancer: Addressing Patient Costs,” “Follow up Care After Breast Cancer Treatment,” “Will My Insurance Cover Alternative and Complementary Therapies?” American Health & Drug Benefits: “Comparison of Treatment Costs for Breast Cancer,… Continue reading Ways to Handle Breast Cancer’s Out-of-Pocket Costs
By Robert PreidtHealthDay Reporter WEDNESDAY, Aug. 11, 2021 (HealthDay News) — Immunotherapy helped extend the lives of some patients with the most common type of advanced colon cancer, researchers report. The new findings are important, they noted, because immunotherapy doesn’t typically work against microsatellite stable (MSS) colon cancer. These patients have few treatment options once… Continue reading Immunotherapy May Help Fight Some Advanced Colon Cancers
By Amy Norton HealthDay Reporter MONDAY, Aug. 9, 2021 (HealthDay News) — An experimental gel has shown early promise in treating the most common form of skin cancer — hinting at a potential alternative to surgery in the future. Researchers tested the gel in 30 patients with basal cell carcinoma (BCC), a skin cancer diagnosed… Continue reading New Drug Might Be Non-Surgical Option for Common Skin Cancers
By Dennis Thompson HealthDay Reporter FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP… Continue reading Drug Lynparza Helps Fight Some Early-Stage Breast Cancers